Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Future Rises After Positive Annual Outlook

Mon, 01st Jul 2019 10:49

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------DS Smith, up 1.7%. The paper and packaging firm said it completed the sale of two packaging businesses in north west France and in Portugal to Memphis, Tennessee-based peer International Paper for EUR63 million. DS Smith said the sale honours the commitment made to the European Commission in relation to the clearance of its acquisition of Spanish packaging firm Europac, which completed in January. Last month, DS Smith had said financial 2019, which ended on April 30, was a "year of good delivery" overall, with "substantial" progress being made overseas and the integration of Europac was going well. Fellow packaging firms Smurfit Kappa and Mondi were up 2.6% and 1.7%, respectively. ----------FTSE 100 - LOSERS----------Fresnillo, down 2.9%. The Mexican gold miner was tracking spot gold prices lower, quoted at USD1,390.28 an ounce, down sharply from USD1,411.62 late Friday. Last week, gold had touched a six-year high of USD1,438.63. Additionally, Fresnillo on Monday said it has decided to align tax treatment for all of the company's underground mining operations, resulting in a USD8.0 million impact on profit for the six months to June-end. Shares in midcap gold miners Centamin and Hochschild Mining also were being hurt by the lower gold price, down 2.2% and 1.7%, respectively.----------International Consolidated Airlines Group, down 1.2%. Bernstein downgraded the airlines operator to Market Perform from Outperform. ----------FTSE 250 - WINNERS----------Future, up 9.0%. The digital media and publishing firm said full-year results will be ahead of expectations, underpinned by good audience growth within the Media division and the continued strong performance of recent acquisitions. The guidance was also attributed to a continuation of positive trends seen in the first half. Future's financial year ends September and will report annual results in November. "Future has a platform which enables it to monetise specialist content through a mixture of e-commerce, getting content users to click through to partnered retailers, events and online advertising. The plan is to feed newly-acquired assets into this platform. Newspaper and magazine publishers continue to battle falling sales and have struggled to get readers to pay for their relatively generic content, but consumers have shown a greater willingness to pay for specialist and niche content which they are unable to get elsewhere," said AJ Bell's Russ Mould.----------FTSE 250 - LOSERS----------John Laing Group, down 1.0%. Barclays started coverage on the infrastructure project investor at Equal Weight. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Tiziana Life Sciences, up 14%. The biotechnology company noted a study in which a drug similar to Foralumab was shown to delay the onset of type-1 diabetes. The phase two study of Teplizumab, an anti-CD3 antibody similar to Foralumab being developed by Provention Bio, was published in the New England Journal of Medicine. Type-1 diabetes is caused by the immune system's T cells attacking insulin-producing cells in the body. Anti-CD3 antibodies like Tiziana's Foralumab and Provention Bio's Teplizumab suppress the immune system to prevent this from happening. Teplizumab is derived from mice and was injected intravenously in patients whose relatives already have type 1 diabetes. Of the 76 patients evaluated, 72% were under 18. The patients were randomised to receive either a 14-day course of Teplizumab or placebo and tested at six-month intervals. At the end of the Teplizumab trial, 57% of participants treated with the drug had not developed diabetes compared to 28% on the placebo.----------OTHER MAIN MARKET AND AIM - LOSERS----------Hurricane Energy, down 17%. The oil and gas explorer said it will abandon and plug the Warwick Deep well after it did not produce at commercial rates. Hurricane had drilled the offshore North Sea well to 1,964 metres, with results indicating a 712-metre horizontal section of fractured basement reservoir. However, initial analysis suggests the well found a "poorly" connected part of the fracture network within the oil column, and the well produced at non-commercial rates. Following plugging and abandoning Warwick Deep, Hurricane will move the rig to the Lincoln Crestal wall, the second of three wells on the Greater Warwick Area.----------

More News
18 May 2021 21:38

IN BRIEF: Tiziana Life Sciences annual loss widens

IN BRIEF: Tiziana Life Sciences annual loss widens

Read more
5 May 2021 19:20

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

Read more
13 Apr 2021 21:56

TRADING UPDATES: Clipper Logistics, JD Sports ink letter of intent

TRADING UPDATES: Clipper Logistics, JD Sports ink letter of intent

Read more
30 Mar 2021 20:34

IN BRIEF: Tiziana plans phase II trials for nasal Covid-19 treatment

IN BRIEF: Tiziana plans phase II trials for nasal Covid-19 treatment

Read more
5 Feb 2021 12:28

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

Read more
2 Feb 2021 11:35

Tiziana Surges As Nasal Therapy May Be Effective In New Virus Variants

Tiziana Surges As Nasal Therapy May Be Effective In New Virus Variants

Read more
27 Jan 2021 14:22

IN BRIEF: Tiziana Files US Statement Over USD250 Million Of Securities

IN BRIEF: Tiziana Files US Statement Over USD250 Million Of Securities

Read more
13 Jan 2021 16:21

UK EXECUTIVE CHANGE SUMMARY: Ex-Savills CEO To Be Tritax Big Box Chair

UK EXECUTIVE CHANGE SUMMARY: Ex-Savills CEO To Be Tritax Big Box Chair

Read more
7 Jan 2021 16:02

UK EXECUTIVE CHANGE SUMMARY: Premier Oil And DP Poland Board Changes

UK EXECUTIVE CHANGE SUMMARY: Premier Oil And DP Poland Board Changes

Read more
4 Jan 2021 15:19

Tiziana completes Covid-19 study in Brazil

(Sharecast News) - Biotechnology company Tiziana Life Sciences announced the completion of its clinical study in Brazil on Monday, investigating nasally-administered Foralumab - its proprietary human monoclonal antibody - either alone or in combination with orally administered dexamethasone in Covid-19 patients.

Read more
4 Jan 2021 12:16

LONDON MARKET MIDDAY: Vaccine Rollouts, M&A And Gold Surge Boost FTSE

LONDON MARKET MIDDAY: Vaccine Rollouts, M&A And Gold Surge Boost FTSE

Read more
4 Jan 2021 12:15

Tiziana Announces Foralumab Trial Completion For Covid-19 Treatment

Tiziana Announces Foralumab Trial Completion For Covid-19 Treatment

Read more
4 Jan 2021 10:44

UK WINNERS & LOSERS SUMMARY: Tui Rises As Tips "Normal" Summer Trading

UK WINNERS & LOSERS SUMMARY: Tui Rises As Tips "Normal" Summer Trading

Read more
17 Dec 2020 19:37

UK TRADING UPDATE SUMMARY: Polar Capital Adds GBP1.2 Billion To Assets

UK TRADING UPDATE SUMMARY: Polar Capital Adds GBP1.2 Billion To Assets

Read more
10 Dec 2020 15:30

UK DIRECTOR DEALINGS SUMMARY: IG Design CEO Sells GBP528,000 In Shares

UK DIRECTOR DEALINGS SUMMARY: IG Design CEO Sells GBP528,000 In Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.